Steatosis is the earliest and most prevalent stage of non-alcoholic fatty liver disease (NAFLD). Although steatosis generally has a benign outcome, some individuals develop progressive liver injury (steatohepatitis or NASH). An issue of primary importance to the understanding of NAFLD remains the study of the biochemical events that change the natural history of the disease from steatosis to NASH. A large majority of obese patients have hepatic steatosis and approximately 30% have NASH. This link is noteworthy, due both to the current obesity epidemic and the increased prevalence of liver damage in obese subjects. Disease progression in NAFLD is currently thought to be triggered by an acute insult or """"""""second hit"""""""" that is superimposed on hepatic steatosis. However, the identity and nature of this """"""""second hit"""""""" remains elusive. In this application, we demonstrate that the composition of fatty acids in the steatotic liver is variable in human obesity. Using dietary models of hepatic steatosis characterized by similar accumulation of total triglyceride but different compositions of fatty acids, we show that steatosis characterized by accumulation of saturated fatty acids leads to increased liver injury and reduced proliferative capacity. Preliminary data suggest that the link between accumulation of saturated fatty acids in the steatotic liver and liver cell injury involves ceramide and the selective upregulation of proapoptotic endoplasmic reticulum proteins. These data lead to the novel hypothesis that the composition of fatty acids in the steatotic liver is an important determinant of liver injury, and therefore may constitute an intrinsic """"""""second hit"""""""". Therefore, the specific aim of this application is to elucidate how saturated fatty acids in the steatotic liver lead to increased liver cell injury. Studies will examine whether 1) de novo ceramide synthesis mediates saturated fatty acid induction of liver injury, 2) differences in fatty acid trafficking determine cytotoxicity, and 3) saturated fatty acids initiate liver cell injury through an endoplasmic reticulum localized apoptotic response.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK072017-04
Application #
7478684
Study Section
Hepatobiliary Pathophysiology Study Section (HBPP)
Program Officer
Doo, Edward
Project Start
2005-09-15
Project End
2010-08-31
Budget Start
2008-09-01
Budget End
2010-08-31
Support Year
4
Fiscal Year
2008
Total Cost
$238,722
Indirect Cost
Name
Colorado State University-Fort Collins
Department
Nutrition
Type
Other Domestic Higher Education
DUNS #
785979618
City
Fort Collins
State
CO
Country
United States
Zip Code
80523
Stewart, Claire; Estrada, Andrea; Kim, Paul et al. (2017) Regulation of IRE1? by the small molecule inhibitor 4?8c in hepatoma cells. Endoplasmic Reticulum Stress Dis 4:1-10
Pagliassotti, Michael J; Estrada, Andrea L; Hudson, William M et al. (2017) Trehalose supplementation reduces hepatic endoplasmic reticulum stress and inflammatory signaling in old mice. J Nutr Biochem 45:15-23
Pagliassotti, Michael J; Kim, Paul Y; Estrada, Andrea L et al. (2016) Endoplasmic reticulum stress in obesity and obesity-related disorders: An expanded view. Metabolism 65:1238-46
Gentile, C L; Weir, T L; Cox-York, K A et al. (2015) The role of visceral and subcutaneous adipose tissue fatty acid composition in liver pathophysiology associated with NAFLD. Adipocyte 4:101-12
Wei, Yuren; Wang, Dong; Moran, Gretchen et al. (2013) Fructose-induced stress signaling in the liver involves methylglyoxal. Nutr Metab (Lond) 10:32
Nivala, Angela M; Reese, Lauren; Frye, Melinda et al. (2013) Fatty acid-mediated endoplasmic reticulum stress in vivo: differential response to the infusion of Soybean and Lard Oil in rats. Metabolism 62:753-60
Wang, Dong; Wei, Yuren; Frye, Melinda et al. (2013) Saturated Fatty Acid-induced cytotoxicity in liver cells does not involve phosphatase and tensin homologue deleted on chromosome 10. J Nutr Metab 2013:514206
Ellis, F; Nivala, A; Pfaffenbach, K T et al. (2012) C-reactive protein does not impair insulin suppression of glucose release in primary hepatocytes. Nutr Metab Cardiovasc Dis 22:115-9
Foster, Michelle T; Pagliassotti, Michael J (2012) Metabolic alterations following visceral fat removal and expansion: Beyond anatomic location. Adipocyte 1:192-199
Gentile, Christopher L; Nivala, Angela M; Gonzales, Jon C et al. (2011) Experimental evidence for therapeutic potential of taurine in the treatment of nonalcoholic fatty liver disease. Am J Physiol Regul Integr Comp Physiol 301:R1710-22

Showing the most recent 10 out of 23 publications